Teratogenicity assessment in pregnant rats receiving 0.2-4 mg/kg intramuscularly during days 6-15 of pregnancy found no effects on fetuses or organ development
An important clinical consideration is the interaction between tirzepatide and oral contraceptives
While there are effective pharmaceutical treatments available that include stimulants and non-stimulants, stimulants are prescribed far more often and can lead to adverse events that include emotional dysregulation, irritability, decreased appetite, insomnia, tachycardia, arrhythmia, and hypertension
There are no known dangerous interactions between most GLP-1 booster ingredients (fiber, probiotics, berberine) and GLP-1 medications, but taking a booster alongside a prescription GLP-1 is largely redundant
Studies eligible for inclusion met all of the following criteria: 1
Khalids complete 7-Day Kidney Stone Prevention Meal Plan as a free, printable PDF